Form D · Pharmaceuticals

LeafBio, Inc.

San Diego, CA · CIK 0001719908

Offering snapshot reported Oct 14, 2022 · SEC filing

Reported sold
$900K
Offering amount: $7.5M
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 18, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$450K$900KOct 17, 2017Oct 12, 2018: $679,062.00Oct 7, 2019: $679,062.00Oct 13, 2020: $679,062.00Oct 12, 2021: $804,696.00Oct 14, 2022: $900,288.00Oct 14, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$804,696 → $900,288
  • Reported investors19 → 21

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 14, 2022Amendment$900,288$95,592vs Oct 12, 202121SEC filing
Oct 12, 2021Amendment$804,696No comparison19SEC filing
Oct 13, 2020Amendment$679,062No comparison16SEC filing
Oct 7, 2019Amendment$679,062$0vs Oct 12, 201816SEC filing
Oct 12, 2018Amendment$679,062No comparison16SEC filing
Oct 11, 2018AmendmentYet to sellNo comparison0SEC filing
Oct 17, 2017InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-296899
This filing relates to grants and sales from time to time pursuant to the LeafBio, Inc. 2017 Long-Term Stock Incentive Plan. Total amount sold includes options granted times exercise price determined at the time of grant.
Interests in a Stock Incentive Plan

Source: Form D, filed Oct 14, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kristen Khanna Director
Kevin Whaley Director, Executive
Larry Zeitlin Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
11760 Sorrento Valley Road, Suite A
San Diego, CA, 92121